ClinVar Miner

Submissions for variant NM_001458.5(FLNC):c.6041T>C (p.Val2014Ala)

gnomAD frequency: 0.00002  dbSNP: rs765064363
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001042923 SCV001206632 uncertain significance Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant 2024-01-22 criteria provided, single submitter clinical testing This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 2014 of the FLNC protein (p.Val2014Ala). This variant is present in population databases (rs765064363, gnomAD 0.005%). This missense change has been observed in individual(s) with frontotemporal dementia (PMID: 26555887). ClinVar contains an entry for this variant (Variation ID: 840829). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on FLNC protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Baylor Genetics RCV001333945 SCV001526661 uncertain significance Hypertrophic cardiomyopathy 26 2018-07-09 criteria provided, single submitter clinical testing This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].
GeneDx RCV001759746 SCV001987718 uncertain significance not provided 2022-09-15 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign in association with an FLNC-related disorder to our knowledge; This variant is associated with the following publications: (PMID: 26555887)
Ambry Genetics RCV002355006 SCV002656725 uncertain significance Cardiovascular phenotype 2019-12-19 criteria provided, single submitter clinical testing The p.V2014A variant (also known as c.6041T>C), located in coding exon 37 of the FLNC gene, results from a T to C substitution at nucleotide position 6041. The valine at codon 2014 is replaced by alanine, an amino acid with similar properties. This variant has been detected in a frontotemporal dementia cohort (Janssens J et al. Acta Neuropathol Commun, 2015 Nov;3:68). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV001333945 SCV002766711 uncertain significance Hypertrophic cardiomyopathy 26 2020-05-25 criteria provided, single submitter clinical testing Based on the classification scheme VCGS_Germline_v0.6.1, this variant is classified as 3B-VUS. Following criteria are met: 0103 - Both loss and gain of function are known mechanism of disease for this gene (PMID:23109048). 0107 - This gene is known to be associated with autosomal dominant disease. 0112 - Variants in this gene are known to have reduced penetrance. Reduced penetrance has been reported in families with familial hypertrophic cardiomyopathy (OMIM). 0200 - Variant is predicted to result in a missense amino acid change from valine to alanine (exon 37). 0302 - Variant is present in gnomAD >=0.0002 and <0.001 for dominant indication (6 heterozygotes, 0 homozygotes). 0309 - An alternative amino acid change at the same position has been observed in gnomAD (p.(Val2014Met): 7 heterozygotes, 0 homozygotes). 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. 0600 - Variant is located in an annotated domain or motif that does not have a well established function (Filamin repeat 18 domain; UniProt). 0705 - No comparable variants in relevant codon/region have previous evidence for pathogenicity. A different variant in the same codon resulting in a change to a methionine has been reported as uncertain clinical significance (ClinVar). 0807 - Variant has not previously been reported in individuals with myopathy or cardiomyopathy, however it has been reported in a patient with frontotemporal dementia without myopathy (PMID:26555887). 0905 - No published segregation evidence has been identified for this variant. 1007 - No published functional evidence has been identified for this variant. 1205 - Variant is maternally inherited.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.